Skip to main content
Erschienen in: Archives of Osteoporosis 1/2015

01.12.2015 | Original Article

The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing’s syndrome

verfasst von: Zhanna E. Belaya, Didier Hans, Liudmila Y. Rozhinskaya, Natalia V. Dragunova, Natalia I. Sasonova, Alexander G. Solodovnikov, Timur T. Tsoriev, Larisa K. Dzeranova, Galina A. Melnichenko, Ivan I. Dedov

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Summary

In a cohort study of 182 consecutive patients with active endogenous Cushing’s syndrome, the only predictor of fracture occurrence after adjustment for age, gender bone mineral density (BMD) and trabecular bone score (TBS) was 24-h urinary free cortisol (24hUFC) levels with a threshold of 1472 nmol/24 h (odds ratio, 3.00 (95 % confidence interval (CI), 1.52–5.92); p = 0.002).

Introduction

The aim was to estimate the risk factors for fracture in subjects with endogenous Cushing’s syndrome (CS) and to evaluate the value of the TBS in these patients.

Methods

All enrolled patients with CS (n = 182) were interviewed in relation to low-traumatic fractures and underwent lateral X-ray imaging from T4 to L5. BMD measurements were performed using a DXA Prodigy device (GEHC Lunar, Madison, Wisconsin, USA). The TBS was derived retrospectively from existing BMD scans, blinded to clinical outcome, using TBS iNsight software v2.1 (Medimaps, Merignac, France). Urinary free cortisol (24hUFC) was measured by immunochemiluminescence assay (reference range, 60–413 nmol/24 h).

Results

Among enrolled patients with CS (149 females; 33 males; mean age, 37.8 years (95 % confidence interval, 34.2–39.1); 24hUFC, 2370 nmol/24 h (2087–2632), fractures were confirmed in 81 (44.5 %) patients, with 70 suffering from vertebral fractures, which were multiple in 53 cases; 24 patients reported non-vertebral fractures. The mean spine TBS was 1.207 (1.187–1.228), and TBS Z-score was −1.86 (−2.07 to −1.65); area under the curve (AUC) was used to predict fracture (mean spine TBS) = 0.548 (95 % CI, 0.454–0.641)). In the final regression model, the only predictor of fracture occurrence was 24hUFC levels (p = 0.001), with an increase of 1.041 (95 % CI, 1.019–1.063), calculated for every 100 nmol/24-h cortisol elevation (AUC (24hUFC) = 0.705 (95 % CI, 0.629–0.782)).

Conclusions

Young patients with CS have a low TBS. However, the only predictor of low traumatic fracture is the severity of the disease itself, indicated by high 24hUFC levels.
Literatur
1.
Zurück zum Zitat Nieman LK, Biller BMK, Finding JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540PubMedPubMedCentralCrossRef Nieman LK, Biller BMK, Finding JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137–195 Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137–195
3.
Zurück zum Zitat Kaltsas G, Makras P (2010) Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy. Neuroendocrinology 92(suppl 1):60–64PubMedCrossRef Kaltsas G, Makras P (2010) Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy. Neuroendocrinology 92(suppl 1):60–64PubMedCrossRef
4.
Zurück zum Zitat Diez-Perez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehbach SH (2011) Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 49:493–498PubMedCrossRef Diez-Perez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehbach SH (2011) Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 49:493–498PubMedCrossRef
5.
Zurück zum Zitat Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat M, Buchfelder J, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JAH, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. Clin Endocrinol Metab 93:2454–2462CrossRef Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat M, Buchfelder J, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JAH, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. Clin Endocrinol Metab 93:2454–2462CrossRef
6.
Zurück zum Zitat Dragunova NV, Belaya ZE, Solodovnikov AG, Rozhinskaya LY, Melnichenko GA (2014) Fractures in patients with endogenous Cushing’s syndrome and their influence on quality of life and functional performance. Osteoporos Int 25(suppl 2):260–261 Dragunova NV, Belaya ZE, Solodovnikov AG, Rozhinskaya LY, Melnichenko GA (2014) Fractures in patients with endogenous Cushing’s syndrome and their influence on quality of life and functional performance. Osteoporos Int 25(suppl 2):260–261
7.
Zurück zum Zitat Dragunova NV, Belaya ZE, Rozhinskaya LY, Melnichenko GA (2014) Bone mineral density, markers of bone remodeling and quality of life in patients with Cushing’s syndrome after 12 months of remission. Endocr Abstr 35:69–70. doi:10.1530/endoabs.35.P24 Dragunova NV, Belaya ZE, Rozhinskaya LY, Melnichenko GA (2014) Bone mineral density, markers of bone remodeling and quality of life in patients with Cushing’s syndrome after 12 months of remission. Endocr Abstr 35:69–70. doi:10.​1530/​endoabs.​35.​P24
8.
9.
Zurück zum Zitat Papadakis G, Uebelhart B, Goumaz M, Zawadynski S, Rizzoli R (2013) An unusual case of hypercortisolism with multiple weight-bearing bone fractures. Clin Cases Miner Bone Metab 10:213–217PubMedPubMedCentral Papadakis G, Uebelhart B, Goumaz M, Zawadynski S, Rizzoli R (2013) An unusual case of hypercortisolism with multiple weight-bearing bone fractures. Clin Cases Miner Bone Metab 10:213–217PubMedPubMedCentral
10.
Zurück zum Zitat Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective long-term study. Eur J Endocrinol 154:109–111PubMedCrossRef Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective long-term study. Eur J Endocrinol 154:109–111PubMedCrossRef
11.
Zurück zum Zitat Szappanos A, Toke J, Lippai D, Patocs A, Igaz P, Szucs N, Futo L, Glaz E, Racz K, Toth M (2010) Bone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment. Osteoporos Int 21:637–645PubMedCrossRef Szappanos A, Toke J, Lippai D, Patocs A, Igaz P, Szucs N, Futo L, Glaz E, Racz K, Toth M (2010) Bone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment. Osteoporos Int 21:637–645PubMedCrossRef
12.
Zurück zum Zitat Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II (2013) Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing’s syndrome. J Osteoporos Int 24:2191–2199CrossRef Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II (2013) Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing’s syndrome. J Osteoporos Int 24:2191–2199CrossRef
13.
Zurück zum Zitat Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787PubMedCrossRef Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 42:775–787PubMedCrossRef
14.
Zurück zum Zitat Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 42:775–787 Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 42:775–787
15.
Zurück zum Zitat Pothuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom 12:170–176PubMedCrossRef Pothuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D (2009) Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom 12:170–176PubMedCrossRef
16.
Zurück zum Zitat Rabier B, Heraud A, Grand-Lenoir C, Winzenrieth R, Hans D (2010) A multicentre, retrospective case-control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): analysing the odds of vertebral fracture. Bone 46:176–181PubMedCrossRef Rabier B, Heraud A, Grand-Lenoir C, Winzenrieth R, Hans D (2010) A multicentre, retrospective case-control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): analysing the odds of vertebral fracture. Bone 46:176–181PubMedCrossRef
17.
Zurück zum Zitat Winzenrieth R, Dufour R, Pothuaud L, Hans D (2010) A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds of vertebral fracture. Calcif Tissue Int 86:104–109PubMedCrossRef Winzenrieth R, Dufour R, Pothuaud L, Hans D (2010) A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds of vertebral fracture. Calcif Tissue Int 86:104–109PubMedCrossRef
18.
Zurück zum Zitat Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769PubMedCrossRef Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769PubMedCrossRef
19.
Zurück zum Zitat Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R (2013) Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 24:77–85PubMedCrossRef Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R (2013) Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 24:77–85PubMedCrossRef
20.
Zurück zum Zitat Leslie WD, Aubry-Rozier B, Lamy O, Hans D (2013) Trabecular bone score and diabetes-related fracture risk. J Clin Endocrinol Metabol 98:602–609CrossRef Leslie WD, Aubry-Rozier B, Lamy O, Hans D (2013) Trabecular bone score and diabetes-related fracture risk. J Clin Endocrinol Metabol 98:602–609CrossRef
21.
Zurück zum Zitat Silva BC, Boutroy S, Zhang C, McMahon DJ, Zhou B, Wang J, Udesky J, Cremers S, Sarquis M, Guo XE, Hans D, Bilezikian JP (2013) Trabecular bone score (TBS)—a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:1963–1970PubMedPubMedCentralCrossRef Silva BC, Boutroy S, Zhang C, McMahon DJ, Zhou B, Wang J, Udesky J, Cremers S, Sarquis M, Guo XE, Hans D, Bilezikian JP (2013) Trabecular bone score (TBS)—a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:1963–1970PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U, Scillitani A, Beck-Peccoz P, Chiodini I (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155–162PubMedCrossRef Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U, Scillitani A, Beck-Peccoz P, Chiodini I (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155–162PubMedCrossRef
23.
Zurück zum Zitat Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I (2012) Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27:2223–2230PubMedCrossRef Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I (2012) Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27:2223–2230PubMedCrossRef
24.
Zurück zum Zitat Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II (2012) Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41:494–500PubMedCrossRef Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II (2012) Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41:494–500PubMedCrossRef
25.
Zurück zum Zitat Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM (2010) AACE Osteoporosis Task Force American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1–37PubMedCrossRef Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM (2010) AACE Osteoporosis Task Force American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1–37PubMedCrossRef
26.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizolli R, Reginster R, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57PubMedPubMedCentralCrossRef Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizolli R, Reginster R, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
28.
Zurück zum Zitat Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 16:455–466PubMedCrossRef Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 16:455–466PubMedCrossRef
29.
Zurück zum Zitat Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135PubMedCrossRef Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135PubMedCrossRef
31.
Zurück zum Zitat Vestergaard P, Lindholm J, Jorgensen JOI, Hagen C, Hoeck HC, Laurbe P, Rejnmark L, Brixen K, Kristensen L, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing’s syndrome. Eur J Endocrinol 146:51–56PubMedCrossRef Vestergaard P, Lindholm J, Jorgensen JOI, Hagen C, Hoeck HC, Laurbe P, Rejnmark L, Brixen K, Kristensen L, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing’s syndrome. Eur J Endocrinol 146:51–56PubMedCrossRef
32.
Zurück zum Zitat Futo L, Toke J, Patocs A, Szappanos A, Varga I, Glaz E, Tulassay Z, Racz K, Toth M (2008) Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing’s syndrome. J Osteoporos Int 19:941–949CrossRef Futo L, Toke J, Patocs A, Szappanos A, Varga I, Glaz E, Tulassay Z, Racz K, Toth M (2008) Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing’s syndrome. J Osteoporos Int 19:941–949CrossRef
33.
Zurück zum Zitat Tauchmaonova L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779–1784CrossRef Tauchmaonova L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779–1784CrossRef
34.
Zurück zum Zitat Eerden AW, den Heijer M, Oyen WJ, Hermus AR (2007) Cushing’s syndrome and bone mineral density: lowest Z-scores in young patients. Neth J Med 65:137–141PubMed Eerden AW, den Heijer M, Oyen WJ, Hermus AR (2007) Cushing’s syndrome and bone mineral density: lowest Z-scores in young patients. Neth J Med 65:137–141PubMed
35.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton J, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellsrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton J, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellsrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef
36.
Zurück zum Zitat Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Fracture and oral corticosteroids: relationship to daily and cumulative dose. Rheumatology (Oxford) 39:1383–1389CrossRef Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Fracture and oral corticosteroids: relationship to daily and cumulative dose. Rheumatology (Oxford) 39:1383–1389CrossRef
37.
Zurück zum Zitat Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM, ERCUSYN Study Group (2011) The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. European J Endocrinology 165:383–392CrossRef Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM, ERCUSYN Study Group (2011) The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. European J Endocrinology 165:383–392CrossRef
38.
Zurück zum Zitat Minne HW, Leidig G, Wuster C, Siromachhkostov K, Bakdauf G, Bickel R, Sauer P, Lojen M, Zeigler R (1988) A newly defined spine deformity index (SDI) to quantitative vertebral crush fractures in patients with osteoporosis. Bone Miner J 3:225–349 Minne HW, Leidig G, Wuster C, Siromachhkostov K, Bakdauf G, Bickel R, Sauer P, Lojen M, Zeigler R (1988) A newly defined spine deformity index (SDI) to quantitative vertebral crush fractures in patients with osteoporosis. Bone Miner J 3:225–349
39.
Zurück zum Zitat Belaya ZE, Rozhinskaya LY, Solodovnikov AG, Dragunova NV, Melnichenko GA: Glucocorticoid-induced osteoporosis: fractures and bone remodeling in patients with endogenous Cushing’s syndrome (2013) Series: Endocrinology Research and Clinical Developments. Online Book, Published by Nova Science Publishers, Inc New York, 55 pp Belaya ZE, Rozhinskaya LY, Solodovnikov AG, Dragunova NV, Melnichenko GA: Glucocorticoid-induced osteoporosis: fractures and bone remodeling in patients with endogenous Cushing’s syndrome (2013) Series: Endocrinology Research and Clinical Developments. Online Book, Published by Nova Science Publishers, Inc New York, 55 pp
Metadaten
Titel
The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing’s syndrome
verfasst von
Zhanna E. Belaya
Didier Hans
Liudmila Y. Rozhinskaya
Natalia V. Dragunova
Natalia I. Sasonova
Alexander G. Solodovnikov
Timur T. Tsoriev
Larisa K. Dzeranova
Galina A. Melnichenko
Ivan I. Dedov
Publikationsdatum
01.12.2015
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2015
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-015-0244-1

Weitere Artikel der Ausgabe 1/2015

Archives of Osteoporosis 1/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.